Clinical Trials Sponsored by Shandong Chest Hospital

Total 1227 results

Beijing Chest Hospital
Shandong Chest Hospital; Zhengzhou Sixth People's Hospital

Active, not recruiting

Early Bactericidal Activity Safety Pulmonary Tuberculosis Pyrifazimine (TBI-166)

Sensitive Pulmonary Tuberculosis

China
Shanghai Chest Hospital

Not yet recruiting

Neoadjuvant Therapy of SBRT Sequencial With Toripalimab and Chemotherapy in Resectable Stage II-III NSCLC Patients(neoR-TORCH) (neoR-TORCH)

Stage II-III Non-small Cell Lung Cancer
Shanghai Chest Hospital

Recruiting

Prediction of Anastomotic Complications and Recurrent Laryngeal Nerve Injury Based on Postoperative Early Endoscopic Evaluation

Anastomotic Leak | Esophageal Neoplasm | Anastomotic Stenosis | Recurrent Laryngeal Nerve Injuries | Endoscopic Evaluation

China
Shanghai Chest Hospital

Not yet recruiting

Neoadjuvant Adebrelimab Plus Chemotherapy for Resectable ESCC: a Single Arm, Prospective Phase 2 Clinical Trial

Esophageal Squamous Cell Carcinoma

China
Shanghai Chest Hospital

Not yet recruiting

RAE Versus MIE in Patients With Esophageal Cancer After Neoadjuvant Therapy

Surgical Procedure, Unspecified

China
Shanghai Chest Hospital

Recruiting

Molecular Analysis and Treatment Options of SCLC

Small Cell Lung Carcinoma | Small-cell Lung Cancer | Small Cell Lung Cancer Limited Stage | Small Cell Lung Cancer Extensive Stage | Small Cell Lung Cancer, Combined Type

China
Shanghai Chest Hospital

Recruiting

Molecular Landscape Analysis and Clinical Implications for NSCLC Patients With Rare Mutations

NSCLC | NSCLC Stage IV | NSCLC, Recurrent

China
Shanghai Chest Hospital

Recruiting

Molecular Analysis and Treatment Options of Thymic Malignancies

Thymic Carcinoma | Thymic Epithelial Tumor | Thymic Cancer

China
Tianjin Chest Hospital

Recruiting

Pembrolizumab as First-line Treatment for Advanced NSCLC Complicated With COPD

NSCLC With COPD

China
Shanghai Chest Hospital

Not yet recruiting

Salvage Immunotherapy and Chemotherapy in Esophageal Squamous Cell Carcinoma Patients Nonresponding to Initial Neoadjuvant Chemoradiotherapy (SINCERE)

Esophageal Squamous Cell Carcinomas
Beijing Chest Hospital

Not yet recruiting

A Study of Camrelizumab Combined With Chemotherapy Sequential Camrelizumab Combined With Apatinib Treatment of Advanced NSCLC

Non-small Cell Lung Cancer
Beijing Chest Hospital

Recruiting

A New Treatment for Primary Smear-positive Pulmonary Tuberculosis With Interleukin-2

Tuberculosis, Pulmonary

China
Shanghai Chest Hospital

Recruiting

ENB-guided Ablation Therapy Combined With VATS in the Treatment of MPLC

Lung Cancer

China
Tianjin Chest Hospital

Recruiting

CCTA Improves Clinical Management of Stable Chest Pain (CICM-SCP)

Coronary Artery Disease | Major Adverse Cardiovascular Events | Coronary Computed Tomography Angiography | Revascularization | Stable Chest Pain | Optimal Medical Therapy | Invasive Coronary Angiography

China
Shanghai Chest Hospital

Recruiting

China Lung Cancer Screening (CLUS) Study Version 2.0

Lung Neoplasms

China
Tianjin Chest Hospital

Recruiting

Intravascular Ultrasound-derived Assessment of Hemodynamically Negative Lesions in NSTEACS Patients (IMPACT-NSTEACS)

Non-ST-segment Acute Coronary Syndrome

China
Shanghai Chest Hospital

Active, not recruiting

To Evaluate the Efficacy of Durvalumab + Anlotinib in Terms of OS and PFS.

Extensive-Stage Small-Cell Lung Cancer

China
Shanghai Chest Hospital

Completed

The Chinese Registration Study of Driver Ablation of Persistent Atrial Fibrillation.

Atrial Fibrillation, Persistent

China
Shanghai Chest Hospital

Unknown

To Evaluate the Role of Postoperative Radiotherapy in Patients With IIIA(N2) Non-Small Cell Lung Cancer

Radiotherapy | Non-small Cell Lung Cancer Stage IIIA

China
Shanghai Chest Hospital

Unknown

Prediction Model of Peripheral Pulmonary Lesions Based on R-EBUS Image (R-EBUS)

Diagnoses Disease

China
Shanghai Chest Hospital

Unknown

Transbronchial Ablation for Peripheral Lung Tumor

Lung Cancer

China
Shanghai Chest Hospital

Unknown

ENB Guided MWA for Early-stage Peripheral Lung Cancer

Lung Cancer

China
Shanghai Chest Hospital

Unknown

Clinical Study of ctDNA and Exosome Combined Detection to Identify Benign and Malignant Pulmonary Nodules (ctDNA)

Pulmonary Nodules

China
Beijing Chest Hospital

Unknown

The Efficacy and Drug Resistance Molecular Biology of Apatinib Combined With EGFR-TK1 Treated for Advanced Slow-progressed Non-Small Cell Lung Cancer (NSCLC)

Non Small Cell Lung Cancer

China
Shanghai Chest Hospital

Unknown

First-line Combination Treatment Based on Anlotinib

Lung Cancer | Advanced Stage

China
Beijing Chest Hospital

Unknown

Optimizing the Therapeutic Dose of Apatinib Mesylate Tablets in Patients With Lung Cancer by Dose Titration：A Real World Exploratory Study

NSCLC Stage IV | NSCLC Stage IIIB
Shanghai Chest Hospital

Unknown

EBUS Image Features in the Diagnosis of PPLs

Endobronchial Ultrasound
Shanghai Chest Hospital

Completed

The Safety and Efficacy of Tolvaptan for Patients With Tricuspid Regurgitation and Right Heart Failure After Left Heart Valves Replacement

Right Heart Failure | Tricuspid Regurgitation

China
Shanghai Chest Hospital

Unknown

Optimization for the Treatment of Advanced Pulmonary Large Cell Neuroendocrine Carcinoma

Pulmonary Large Cell Neuroendocrine Carcinoma
Shanghai Chest Hospital

Unknown

18F-FDG Metabolism Imaging Monitoring Non-small Cell Lung Cancer Curative Effect of Chemotherapy Multicenter Clinical Study

Non-small-cell Lung Cancer
Shanghai Chest Hospital

Unknown

Early Stage Lung Cancer Screening With Low-dose Computed Tomographic

Lung Cancer

China
Shanghai Chest Hospital

Unknown

Recombinant BNP on Heart and Renal Function in Acute Heart Failure

Acute Renal Failure | Acute Heart Failure

China
Shanghai Chest Hospital

Recruiting

A Study of Molecular Residual, Dynamic Monitoring and Recurrence of Stage III Driver Mutated NSCLC

Non Small Cell Lung Cancer

China
Shanghai Chest Hospital

Not yet recruiting

Neoadjuvant PD-1 Blockade for Elderly Esophageal Squamous Cell Carcinoma (BLESS) (BLESS)

Esophageal Cancer

China
Shanghai Chest Hospital

Recruiting

Predicting Non-small Cell Lung Cancer (NSCLC) Lymph Node Metastasis: Integrating Circulating Tumor DNA (ctDNA) Mutation/ Methylation Profiling With Positron Emission Tomography-computed Tomography (PET-CT) Scan

Carcinoma | Non-small Cell Lung Cancer

China
Shanghai Chest Hospital

Recruiting

Association of Psychological Distress in Patients With Lung Cancer (Life-Score)

Lung Neoplasms | Psychological Distress | IMMUNOTHERAPY | Lifestyle, Healthy | Targeted Molecular Therapy | Prognosis Factors

China
Beijing Chest Hospital

Not yet recruiting

Effect of Compound Amino Acid Tablets on Nutritional Status of Patients With Lung Cancer

Malnutrition | Lung Cancer | Amino Acid Deficiency
Shanghai Chest Hospital

Not yet recruiting

Camrelizumab Combined With Neoadjuvant Concurrent Chemoradiotherapy for Resectable Locally Advanced ESCC（NICE-RT）

Esophageal Squamous Cell Carcinoma

China
Shanghai Chest Hospital

Recruiting

Feasibility of Thin Cp-EBUS Scope BF-UC290F for the Diagnosis of PPLs

Peripheral Pulmonary Nodules

China
Shanghai Chest Hospital

Recruiting

Sintilimab Combined With Anlotinib for Perioperative Non-small Cell Lung Cancer Based on MRD Evaluation

Non-small Cell Lung Cancer | Minimal Residual Disease | Immunotherapy | Anti-angiogenesis

China
Shanghai Chest Hospital

Not yet recruiting

Catheter Ablation and Surgical Ablation of Persistent Atrial Fibrillation With Severe Atrial Fibrosis

Persistent Atrial Fibrillation
Shanghai Chest Hospital

Not yet recruiting

Driver Ablation of Persistent Atrial Fibrillation With Severe Atrial Fibrosis.

Persistent Atrial Fibrillation
Shanghai Chest Hospital

Not yet recruiting

A Phase II Trial of Camrelizumab Combined With Famitinib for Adjuvant Treatment of Stage II-IIIA NSCLC. (CAMFA-L)

NSCLC

China
Shanghai Chest Hospital

Not yet recruiting

Almonertinib Versus Osimertinib in the Patients With EGFR Mutations in Advanced NSCLC With Brain Metastases (ATTACK)

NSCLC
Shanghai Chest Hospital

Not yet recruiting

To Evaluate the Efficacy of Afatinib in the Treatment of Locally Advanced/Metastatic Non-Small Cell Lung Cancer With NRG1 Fusion

NRG1-fused Non-small Cell Lung Cancer

China
Beijing Chest Hospital

Recruiting

Randomized Controlled Multi-center Short Course Treatment for Rifampicin Resistant Tuberculosis

Tuberculosis

China
Shanghai Chest Hospital

Recruiting

Tislelizumab Combined With Chemotherapy With or Without Bevacizumab in TKI-Resistant EGFR-Mutated Non-squamous NSCLC

Non Small Cell Lung Cancer

China
Shanghai Chest Hospital

Recruiting

Pyrotinib Plus Thalidomide in Advanced NSCLC Patients Harboring HER2 Exon 20 Insertions

Non-small-cell Lung Cancer

China
Tianjin Chest Hospital

Recruiting

Effect of Evolocumab Added to Moderate-Intensity Statin Therapy on LDL-C Lowering and Cardiovascular Adverse Events in Patients With Acute Coronary Syndrome (EMSIACS)

Acute Coronary Syndrome | Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor

China
Shanghai Chest Hospital

Completed

Trametinib Plus Anlotinib in Non-G12C KRAS-Mutant NSCLC Patients

Non Small Cell Lung Cancer

China

3

Subscribe